SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer

NCT03443492 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced or Metastatic Pancreatic Cancer

Interventions

DRUG: S-1
DRUG: Leucovorin(oral )
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Irinotecan
DRUG: 5-FU
DRUG: Leucovorin(IV)

Sponsor

National Health Research Institutes, Taiwan

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]